Literature DB >> 28183333

Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer.

Zhi Hu1, Jian-Hua Mao2, Christina Curtis3, Ge Huang1, Shenda Gu1, Laura Heiser1, Marc E Lenburg4, James E Korkola1, Nora Bayani2, Shamith Samarajiwa5, Jose A Seoane3, Mark A Dane1, Amanda Esch1, Heidi S Feiler1, Nicholas J Wang1, Mary Ann Hardwicke6, Sylvie Laquerre6, Jeff Jackson6, Kenneth W Wood7, Barbara Weber6, Paul T Spellman1, Samuel Aparicio8, Richard Wooster6, Carlos Caldas9, Joe W Gray10.   

Abstract

Entities:  

Year:  2017        PMID: 28183333      PMCID: PMC5301377          DOI: 10.1186/s13058-017-0809-6

Source DB:  PubMed          Journal:  Breast Cancer Res        ISSN: 1465-5411            Impact factor:   6.466


× No keyword cloud information.

Erratum

In the version of this article that was published on PubMed [1] the author’s name “Mark A. Dane” was formatted incorrectly in the XML mark up and therefore appeared incorrectly on PubMed. In the XML mark up, the middle initial “A” was added as a Particle when it should have been included as a Given Name. Due to this error, the author’s name was incorrectly formatted in PubMed as “A Dane M” and not as “Dane MA”. The author’s name is correct on the BioMed Central website. The author's name in the XML of the original article [1] has been updated accordingly.
  1 in total

1.  Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer.

Authors:  Zhi Hu; Jian-Hua Mao; Christina Curtis; Ge Huang; Shenda Gu; Laura Heiser; Marc E Lenburg; James E Korkola; Nora Bayani; Shamith Samarajiwa; Jose A Seoane; Mark A Dane; Amanda Esch; Heidi S Feiler; Nicholas J Wang; Mary Ann Hardwicke; Sylvie Laquerre; Jeff Jackson; Kenneth W Wood; Barbara Weber; Paul T Spellman; Samuel Aparicio; Richard Wooster; Carlos Caldas; Joe W Gray
Journal:  Breast Cancer Res       Date:  2016-07-01       Impact factor: 6.466

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.